- Home
- AQST vs ABEO Comparison
AQST vs ABEO Comparison
Compare AQST & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- AQST
- ABEO
- Stock Information
- Founded
- AQST 2004
- ABEO N/A
- Country
- AQST United States
- ABEO United States
- Employees
- AQST N/A
- ABEO N/A
- Industry
- AQST Biotechnology: Pharmaceutical Preparations
- ABEO Biotechnology: Pharmaceutical Preparations
- Sector
- AQST Health Care
- ABEO Health Care
- Exchange
- AQST Nasdaq
- ABEO Nasdaq
- Market Cap
- AQST 254.1M
- ABEO 237.4M
- IPO Year
- AQST 2018
- ABEO 1980
- Fundamental
- Price
- AQST $2.51
- ABEO $4.84
- Analyst Decision
- AQST Strong Buy
- ABEO Strong Buy
- Analyst Count
- AQST 6
- ABEO 5
- Target Price
- AQST $11.17
- ABEO $17.00
- AVG Volume (30 Days)
- AQST 1.4M
- ABEO 821.9K
- Earning Date
- AQST 05-06-2025
- ABEO 05-14-2025
- Dividend Yield
- AQST N/A
- ABEO N/A
- EPS Growth
- AQST N/A
- ABEO N/A
- EPS
- AQST N/A
- ABEO N/A
- Revenue
- AQST $57,561,000.00
- ABEO N/A
- Revenue This Year
- AQST N/A
- ABEO N/A
- Revenue Next Year
- AQST $39.51
- ABEO $539.93
- P/E Ratio
- AQST N/A
- ABEO N/A
- Revenue Growth
- AQST 13.79
- ABEO N/A
- 52 Week Low
- AQST $2.20
- ABEO $3.05
- 52 Week High
- AQST $5.80
- ABEO $8.45
- Technical
- Relative Strength Index (RSI)
- AQST 41.88
- ABEO 49.29
- Support Level
- AQST $2.20
- ABEO $3.93
- Resistance Level
- AQST $2.61
- ABEO $5.02
- Average True Range (ATR)
- AQST 0.22
- ABEO 0.41
- MACD
- AQST -0.03
- ABEO 0.06
- Stochastic Oscillator
- AQST 36.47
- ABEO 83.49
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.
About ABEO Abeona Therapeutics Inc.
Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.